> ้ฆ™ๆธฏ6ๅ’Œๅˆๅฝฉๅฎ˜็ฝ‘ๅผ€ๅฅ–็ฝ‘็ซ™ - ้ฆ™ๆธฏ6ๅ’Œๅˆๅฝฉๅฎ˜็ฝ‘ๅผ€ๅฅ–็ป“ๆžœ+ๅŽ†ๅฒๅผ€ๅฅ–ๅท็  | ๅฎ˜ๆ–นๅฝฉ็ฅจ็ฝ‘ๅ€ us-best.com | BioNTech

OUR VISION

Harnessing the power of the immune system to develop novel therapies against cancer and infectious diseases

mRNA Therapeutics
้ฆ™ๆธฏ6ๅ’Œๅˆๅฝฉๅฎ˜็ฝ‘ๅผ€ๅฅ–็ป“ๆžœ+ๅŽ†ๅฒๅผ€ๅฅ–ๅท็ 
Antibodies
Small Molecule Immunomodulators

Pipeline – Explore our product candidates

A diversified pipeline of more than 20 product candidates for cancer and infectious diseases accross four drug classes

Learn More

Our Newsroom

้ฆ™ๆธฏ6ๅ’Œๅˆๅฝฉๅฎ˜็ฝ‘ๅผ€ๅฅ–็ฝ‘็ซ™ - ๅฎ˜ๆ–น็ฝ‘ๅ€ us-best.com

A team of first-movers and experienced entrepreneurs grounded in scientific rigor

LEARN MORE
Ugur Sahin Chief Executive Officer
Sean Marett Chief Business and Chief Commercial Officer
Sierk Poetting Chief Operating Officer
Jens Holstein Chief Financial Officer
Özlem Türeci Chief Medical Officer
Ryan Richardson Chief Strategy Officer

We are revolutionizing cancer medicine.
Join us and be a part of our unique pionieering spirit.

CONTACT

Questions about our products, services or clinical trials?

Please contact us
ๅผ€ๅฅ–็ฝ‘็ซ™ ้ฆ™ๆธฏ6ๅˆๅ’Œๅฝฉ็”Ÿ่‚–ๆ•ฐๅญ—2022 ๆพณ้—จๅ…ญ็›’ๅฎๅ…ธ2022ๅนดๆœ€ๆ–ฐ็‰ˆๅผ€ๅฅ– ๆž้€Ÿ6ๅˆ5ๅˆ†้’Ÿๅฎ˜็ฝ‘ ไธ€ๅˆ†้’Ÿๆž้€Ÿ่ต›่ฝฆๅผ€ๅฅ–็ฝ‘ sg้ฃž่‰‡ๅผ€ๅฅ–็›ดๆ’ญ็ฝ‘ ๅนธ่ฟ้ฃž่กŒ่‰‡168ๅฝฉ็ฅจๅผ€ๅฅ–ๅฎ˜ๆ–น 2022ๆž้€Ÿ้ฃž่‰‡168ๅฎ˜็ฝ‘ ๆพณๆดฒๅนธ่ฟ5ๅผ€ๅฅ–ๅท็ ็ป“ๆžœ ๆพณๆดฒๅนธ่ฟ8ๅผ€ๅฅ–็›ดๆ’ญๅฎ˜ๆ–น ๆพณๆดฒๅนธ่ฟ10ๅผ€ๅฅ–็›ดๆ’ญ ๅฐๆนพๅคงไน้€ๅฎ˜ๆ–น็ฝ‘็ซ™ๅผ€ๅฅ–็ป“ๆžœ PC่›‹่›‹ๅนธ่ฟ28ๅœจ็บฟ็›ดๆ’ญๅผ€ๅฅ–็ป“ๆžœ ๆฒณๅ†…5ๅˆ†ๅฝฉ่ถŠๅ—ๅฎ˜ๆ–นๅผ€ๅฅ–็ฝ‘

Temp JS

p4-css-global

p4-css-templates-a

p4-css-templates-b

Temp JS

p4-css-global

p4-css-templates-a

p4-css-templates-b